This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Giafis, N. Articles by Platanias, L. C. Search for Related Content PubMed PubMed Citation Articles by Giafis, N. Articles by Platanias, L. C.

Role of the p38 Mitogen-Activated Protein Kinase Pathway in the Generation of Arsenic Trioxide–Dependent Cellular Responses

¹ Robert H. Lurie Comprehensive Cancer Center and Division of Hematology-Oncology, Department of Medicine, Northwestern University Medical School, Chicago, Illinois; ² Scios, Inc., Fremont, California; ³ CNIO (Spanish National Cancer Center), Madrid, Spain; and ⁴ Howard Hughes Medical Institute and Program in Molecular Medicine, University of Massachusetts, Worcester, Massachusetts

Requests for reprints: Leonidas C. Platanias, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Medical School, 303 East Superior Street, Lurie 3-107, Chicago, IL 60611. Phone: 312-503-4267; Fax. 312-908-1372; E-mail: l-platanias{at}northwestern.edu.

Arsenic trioxide (As₂O₃) induces differentiation and apoptosis of leukemic cells in vitro and in vivo, but the precise mechanisms that mediate such effects are not known. In the present study, we provide evidence that the kinases MAPK kinase 3 (Mkk3) and Mkk6 are activated during treatment of leukemic cell lines with As₂O₃ to regulate downstream engagement of the p38 mitogen-activated protein kinase. Using cells with targeted disruption of both the Mkk3 and Mkk6 genes, we show that As₂O₃-dependent activation of p38 is defective in the absence of Mkk3 and Mkk6, establishing that these kinases are essential for As₂O₃-dependent engagement of the p38 pathway. Pharmacologic inhibition of p38 enhances As₂O₃-dependent activation of the c-jun NH₂-terminal kinase (JNK) and subsequent induction of apoptosis of chronic myelogenous leukemia (CML)– or acute promyelocytic leukemia (APL)–derived cell lines. In addition, in APL blasts, inhibition of p38 enhances myeloid cell differentiation in response to As₂O₃, as well as suppression of Bcl-2 expression and loss of mitochondrial membrane potential. Similarly, induction of As₂O₃-dependent apoptosis is enhanced in mouse embryonic fibroblasts (MEF) with targeted disruption of both the Mkk3 and Mkk6 genes, establishing a key role for this pathway in the regulation of As₂O₃-induced apoptosis. In other studies, we show that the small-molecule p38 inhibitors SD-282 and SCIO-469 potentiate As₂O₃-mediated suppression of myeloid leukemic progenitor growth from CML patients, indicating a critical regulatory role for p38 in the induction of antileukemic responses. Altogether, our data indicate that the Mkk3/6-p38 signaling cascade is activated in a negative regulatory feedback manner to control induction of As₂O₃-mediated antileukemic effects. (Cancer Res 2006; 66(13): 6763-71)

This article has been cited by other articles:

				E. Katsoulidis, N. Carayol, J. Woodard, I. Konieczna, B. Majchrzak-Kita, A. Jordan, A. Sassano, E. A. Eklund, E. N. Fish, and L. C. Platanias Role of Schlafen 2 (SLFN2) in the Generation of Interferon {alpha}-induced Growth Inhibitory Responses J. Biol. Chem., September 11, 2009; 284(37): 25051 - 25064. [Abstract] [Full Text] [PDF]

				L. C. Platanias Biological Responses to Arsenic Compounds J. Biol. Chem., July 10, 2009; 284(28): 18583 - 18587. [Abstract] [Full Text] [PDF]

				A. J. Redig, A. Sassano, B. Majchrzak-Kita, E. Katsoulidis, H. Liu, J. K. Altman, E. N. Fish, A. Wickrema, and L. C. Platanias Activation of Protein Kinase C{eta} by Type I Interferons J. Biol. Chem., April 17, 2009; 284(16): 10301 - 10314. [Abstract] [Full Text] [PDF]

				F. Binet and D. Girard Novel human neutrophil agonistic properties of arsenic trioxide: involvement of p38 mitogen-activated protein kinase and/or c-jun NH2-terminal MAPK but not extracellular signal-regulated kinases-1/2 J. Leukoc. Biol., December 1, 2008; 84(6): 1613 - 1622. [Abstract] [Full Text] [PDF]

				J. K Altman, H. Glaser, A. Redig, A. Sassano, M. S Tallman, and L. C Platanias Targeting the Mnk Pathway Enhances Chemotherapy-Induced Antileukemic Responses. Blood (ASH Annual Meeting Abstracts), November 16, 2008; 112(11): 1617 - 1617. [Abstract]

				I. Migdal, Y. Ilina, M. J. Tamas, and R. Wysocki Mitogen-Activated Protein Kinase Hog1 Mediates Adaptation to G1 Checkpoint Arrest during Arsenite and Hyperosmotic Stress Eukaryot. Cell, August 1, 2008; 7(8): 1309 - 1317. [Abstract] [Full Text] [PDF]

				J. Woodard, A. Sassano, N. Hay, and L. C. Platanias Statin-Dependent Suppression of the Akt/Mammalian Target of Rapamycin Signaling Cascade and Programmed Cell Death 4 Up-Regulation in Renal Cell Carcinoma Clin. Cancer Res., July 15, 2008; 14(14): 4640 - 4649. [Abstract] [Full Text] [PDF]

				A. Yoda, K. Toyoshima, Y. Watanabe, N. Onishi, Y. Hazaka, Y. Tsukuda, J. Tsukada, T. Kondo, Y. Tanaka, and Y. Minami Arsenic Trioxide Augments Chk2/p53-mediated Apoptosis by Inhibiting Oncogenic Wip1 Phosphatase J. Biol. Chem., July 4, 2008; 283(27): 18969 - 18979. [Abstract] [Full Text] [PDF]

				B. Dolniak, E. Katsoulidis, N. Carayol, J. K. Altman, A. J. Redig, M. S. Tallman, T. Ueda, R. Watanabe-Fukunaga, R. Fukunaga, and L. C. Platanias Regulation of Arsenic Trioxide-induced Cellular Responses by Mnk1 and Mnk2 J. Biol. Chem., May 2, 2008; 283(18): 12034 - 12042. [Abstract] [Full Text] [PDF]

				J. K. Altman, P. Yoon, E. Katsoulidis, B. Kroczynska, A. Sassano, A. J. Redig, H. Glaser, A. Jordan, M. S. Tallman, N. Hay, et al. Regulatory Effects of Mammalian Target of Rapamycin-mediated Signals in the Generation of Arsenic Trioxide Responses J. Biol. Chem., January 25, 2008; 283(4): 1992 - 2001. [Abstract] [Full Text] [PDF]